Home Top Movers Why did Synlogic Inc. (SYBX) stock turnaround in the after-hours on Friday?

Why did Synlogic Inc. (SYBX) stock turnaround in the after-hours on Friday?

Synlogic Inc. (SYBX) shares gained 7.45% to trade at $3.75 in after-market on Friday, April 30, 2021. Earlier, SYBX’s stock lost -2.51% to close Friday’s session at $3.49. SYBX shares have surged 67.79% over the last 12 months, and they have moved down 6.68% in the past week. Over the past three months, the stock has lost 5.93%, while over the past six months, it has added 85.64%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Let’s see why  SYBX performed well in the after-hours on Friday?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Common stock pricing announcement

On April 16, 2021, Synlogic revealed the pricing for its previously announced offer of 10,000,000 shares of its common stock. The company announced the offering price of $3.00 per share.

Read More

The underwriter also has a 30-day option to purchase up to 1,500,000 additional shares of common stock at the public offering price. The gross proceeds of approximately $30.0 million are expected to be generated from the offer.

SVB Leerink is acting as the sole book-running manager for the offering.

Presenting Phase1 study data of SYNB1618

On April 13, 2021, Synlogic, Inc announced to present the Phase1study data of SYNB1618 at the American College of Medical Genetics (ACMG) annual meeting, which held virtually on April 13-16, 2021.

SYNB1618 is used for the treatment of Phenylketonuria (PKU) and is designed to break down phenylalanine in the GI tract as a potential treatment for patients with PKU.

SYNB1891 data presentation

Synlogic presented SYNB1891data at the American Association for Cancer Research (AACR) annual meeting which held on April 10-15, 2021.

SYNB1891 is used for the treatment of solid tumors and lymphoma and the presentation was delivered by Dr. Filip Janku, Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.

Recent financial results announcement

On March 25, 2021, Synlogic released financial results for the fourth quarter, and the full-year ended December 31, 2020.

Fourth Quarter 2020 financial highlights

  • Synlogic reported a consolidated net loss of $14.6 million, or $0.39 per share for Q4 2020 compared to a consolidated net loss of $12.8 million, or $0.37 per share, for Q4 2019.
  • It spent $11.4 million in research and development expenses for the three months ended December 31, 2020, compared to $11.3 million for the same period in 2019.
  • General and administrative expenses for the three months ended December 31, 2020, were $3.3 million compared to $3.5 million for the corresponding period in 2019.
  • Synlogic earned no revenue in Q4 2020 compared to $1.2 million for the three months ended December 31, 2019.

The full Year 2020 financial highlights

  • Synlogic suffered a net loss of $59.2 million, or $1.65per share in FY 2020 compared to a consolidated net loss of $51.4 million, or $1.70 per share, for the year ended December 31, 2019.
  • FY 2020 revenue was $0.5 million compared to $2.2 million in FY 2019.
  • Total operating expenses were $61.0 million for FY 2020 compared to $56.6 million for 2019.
  • Synlogic had cash, cash equivalents, and short-term investments of $100.4 million, as of December 31, 2020.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Well, there are no recent developments about SYBX stock, and its turnaround on Friday is strange. We will wait and see how it will start the new week on Monday.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Himax Technologies, Inc. (HIMX) Stock Climbing After Promising Q1 2021 Financial Reports

Himax Technologies, Inc. (HIMX) stock prices were down by 6.97% as of the market closing on May 5th 2021, bringing the price per share...

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went...

Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit

Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to...

Shares of Cinedigm Corp. (CIDM) are climbing high in the premarket. What’s Going On?

Cinedigm (NASDAQ:CIDM), a distributor of various movies, television and other digital content, managing a library of distribution rights to several thousand titles and different...

Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?

Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.